DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Maruyama D, Hatake K, Kinoshita T. et al.
A multicenter phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma.
Cancer Sci 2017;
108: 1007-1012
We do not assume any responsibility for the contents of the web pages of other providers.